AzTrials
AzTrials

Sarcopenia in ElderlyNCT07859969

The Effect of Adding Elastic Resistance Training in Routine Physical Exercise on Walking Speed of Elderly People With Sarcopenia in Griya Wreda Jambangan, Surabaya

A study testing Elastic Resistance Training and Routine Physical Exercise in people with Sarcopenia in Elderly, run by Dr. Soetomo General Hospital at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomized clinical trial is to learn whether adding elastic resistance training (ERT) to routine physical exercise can improve walking speed in older adults aged 60 years or older with sarcopenia living at Griya Wreda Jambangan, Surabaya. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Sarcopenia in Elderly
What is being tested?
Elastic Resistance Training and Routine Physical Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteIndonesia
Study dates
1 May 2026to 18 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 60 years or older.
  • Resident of Griya Wreda Jambangan, Surabaya.
  • Meets the diagnostic criteria for sarcopenia according to the Asian Working Group for Sarcopenia (AWGS) 2019.
  • Able to ambulate independently, with or without a walking aid, and has a --Barthel Index score ≥60.
  • Adequate visual and hearing function.
  • No cognitive impairment that would interfere with understanding and following instructions, defined as a Montreal Cognitive Assessment-Indonesian Version (MoCA-INA) score ≥26.
  • Body mass index of 18.5-24.9 kg/m² according to the Asia-Pacific classification.
  • Willing to participate in the study and provides written informed consent after receiving an explanation of the study.

Who cannot join

  • Cardiorespiratory disease that may affect physical performance during exercise, including New York Heart Association class III-IV heart failure, chronic obstructive pulmonary disease, acute myocardial infarction, unstable angina, uncontrolled arrhythmia, aneurysm, severe aortic stenosis, acute endocarditis or pericarditis, persistent asthma, or acute or severe respiratory failure.
  • Blood pressure ≥180/100 mmHg.
  • Uncontrolled postural hypotension.
  • Acute thromboembolism, including deep vein thrombosis.
  • Infectious disease that may affect the participant's general condition or ability to perform the exercise program.
  • Anatomical abnormality of the upper extremity that prevents handgrip strength assessment.
Show all 11Show fewer
  • Fracture within the previous 3 months, or a fracture occurring more than 3 months previously that has not achieved union or interferes with the intervention.
  • Lower-extremity musculoskeletal disorder with muscle or joint pain rated ≥4 on the Wong-Baker Faces Pain Scale and clinical signs of swelling, redness, or warmth.
  • Chronic disease that interferes with mobility, including ambulatory impairment due to stroke, uncontrolled diabetes mellitus, or balance disorders due to intracranial or extracranial conditions such as benign paroxysmal positional vertigo or other neurological disorders affecting balance.
  • Anatomical abnormality of the lower extremity that prevents walking-speed assessment.
  • Participation in a specific physical exercise program other than the routine physical exercise provided at the nursing home within the previous 3 months.

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Griya Wreda Jambangan

    Surabaya, East Java

Other trials in Indonesia

About this study

Official title: Elastic Resistance Training for Older Adults With Sarcopenia

The goal of this randomized clinical trial is to learn whether adding elastic resistance training (ERT) to routine physical exercise can improve walking speed in older adults aged 60 years or older with sarcopenia living at Griya Wreda Jambangan, Surabaya. Sarcopenia is identified according to the Asian Working Group for Sarcopenia (AWGS) 2019 criteria.

The main questions it aims to answer are:

Read more
  • Does adding elastic resistance training to routine physical exercise improve walking speed after 8 weeks?
  • Is the change in walking speed greater in participants who receive elastic resistance training plus routine physical exercise than in those who receive routine physical exercise alone? Researchers will compare routine physical exercise plus elastic resistance training with routine physical exercise alone to determine whether the addition of elastic resistance training results in greater improvement in walking speed. The study uses a randomized pre- and post-intervention controlled design.

Participants will:

  • Be randomly assigned to either the intervention group or the control group.
  • Continue the routine physical exercise program provided at Griya Wreda Jambangan.
  • If assigned to the intervention group, perform elastic resistance training for the upper and lower extremities twice per week for 8 weeks, in addition to routine physical exercise.
  • Have their walking speed measured before and after the 8-week intervention using a walking test over the middle 6 meters of a 10-meter walkway.
  • Undergo clinical screening and monitoring to ensure that exercise participation is safe.
Read the detailed description

This is a randomized controlled clinical trial with a pre- and post-intervention design conducted in older adults with sarcopenia residing at Griya Wreda Jambangan, Surabaya. The study is designed to evaluate whether adding elastic resistance training (ERT) to the participants' routine physical exercise program improves physical performance, particularly walking speed, compared with routine physical exercise alone. Participants are assigned to an intervention group or a control group, and assessments are performed before and after the 8-week intervention period.

Participants in both groups continue the routine physical exercise program provided at Griya Wreda Jambangan. This program includes aerobic and flexibility components and is performed at least three times per week for approximately 30 minutes per session. Attendance is recorded to monitor adherence to the routine exercise program.

In addition to routine physical exercise, participants in the intervention group receive a structured progressive ERT program using elastic resistance bands. The ERT program is performed twice per week on nonconsecutive days for 8 weeks, with each session lasting approximately 30-45 minutes. Each session includes a warm-up, resistance exercises targeting major upper- and lower-extremity muscle groups, and a cool-down. Upper-extremity exercises include seated chest press, seated row, and seated shoulder press. Lower-extremity exercises include standing hip abduction, standing hip adduction, seated leg press, and standing leg curl.

Resistance exercises are performed for three sets of 10-20 repetitions per exercise, with 30-60 seconds of rest between sets. Exercise intensity is prescribed at a moderate perceived level using the OMNI-Resistance Exercise Scale, and resistance is progressively increased according to the participant's ability to complete the prescribed repetitions at the target perceived exertion. When a participant is able to complete 20 repetitions at the specified target exertion, progression is made by using an elastic band with greater resistance. This approach is intended to provide progressive overload while allowing the training load to be individualized according to each participant's capacity.

The control group receives the same routine physical exercise program but does not receive the additional ERT intervention during the 8-week study period. Walking performance is assessed in both groups before initiation of the intervention and again after completion of the 8-week period. The protocol specifies that baseline assessment is performed approximately 2 days before the intervention and post-intervention assessment approximately 2 days after the final intervention session.

Walking speed is assessed at the participant's usual comfortable walking speed on a 10-meter level walkway. The first 2 meters are used for acceleration and the final 2 meters for deceleration, while the middle 6 meters are timed. Participants complete two trials with a rest interval between trials, and the walking-speed value is calculated from the time required to traverse the timed 6-meter section. The protocol uses the average value from the two trials for analysis. Participants who routinely use a walking aid are permitted to use it during testing.

Participant safety is monitored throughout the exercise program. Before ERT sessions, participants undergo clinical assessment to confirm that they are fit to exercise. Blood pressure, heart rate, respiratory rate, body temperature, and oxygen saturation are assessed around the exercise sessions, and symptoms are monitored during training. The protocol includes predefined criteria for withholding or terminating exercise when symptoms or abnormal physiologic responses occur. Exercise is stopped if clinically concerning symptoms develop, if physiologic safety limits are exceeded, if oxygen saturation falls below 90% or decreases substantially from baseline, or if the participant wishes to stop.

Adherence to the ERT intervention is documented through session attendance and standardized exercise records, including vital signs, perceived exertion, symptoms, and reasons for exercise termination when applicable. The protocol also specifies withdrawal criteria for participants who discontinue participation, become unable to continue exercise because of illness, or miss the prespecified number of intervention sessions.

The statistical analysis plan includes assessment of data distribution using normality testing. Within-group pre- and post-intervention comparisons are analyzed using a paired t-test when assumptions for parametric analysis are met, with the Wilcoxon signed-rank test as the nonparametric alternative. Between-group comparisons are performed using an independent-samples t-test, with the Mann-Whitney U test used when data are not normally distributed. Statistical analyses are performed using SPSS.

Being tested
Elastic Resistance Training, Routine Physical Exercise
Keywords
Sarcopenia, Older Adults, Aged, Elastic Resistance Training, Resistance Training, Gait Speed, Physical Performance, Long-Term Care, Exercise
Medical subject headings
Sarcopenia, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Elastic Resistance TrainingBehavioural

    Elastic resistance training is performed using elastic bands twice per week on nonconsecutive days for 8 weeks. Each session lasts approximately 30-45 minutes and includes warm-up, resistance exercises, and cool-down. Exercises include seated chest press, seated row, seated shoulder press, standing hip abduction, standing hip adduction, seated leg press, and standing leg curl. Each exercise is performed for 3 sets of 10-20 repetitions at moderate intensity (OMNI-RES rating of perceived exertion 4-6), with 30-60 seconds of rest between sets. Resistance is progressively increased when the participant can complete 20 repetitions at the target perceived exertion.

  • Routine Physical ExerciseBehavioural

    Routine physical exercise is the existing exercise program provided at Griya Wreda Jambangan. The program consists primarily of aerobic and flexibility exercises performed at least three times per week for approximately 30 minutes per session throughout the 8-week study period. The program includes warm-up exercises, stretching and mobility exercises, aerobic movements, and cool-down activities.

Study groups in NCT07859969
Study groupRoleWhat they receive
Routine Physical Exercise + Elastic Resistance TrainingExperimentalParticipants in this arm continue the routine physical exercise program provided at Griya Wreda Jambangan and receive additional elastic resistance training twice per week on nonconsecutive days for 8 weeks. Each elastic resistance training session lasts approximately 30-45 minutes and includes warm-up, progressive resistance exercises for the upper and lower extremities, and cool-down. Exercises include seated chest press, seated row, seated shoulder press, standing hip abduction, standing hip adduction, seated leg press, and standing leg curl. Resistance is progressively increased according to the participant's exercise capacity and perceived exertion.
Receives: Behavioral: Elastic Resistance Training; Behavioral: Routine Physical Exercise
Routine Physical ExerciseActive comparatorParticipants in this arm continue the routine physical exercise program provided at Griya Wreda Jambangan without additional elastic resistance training for 8 weeks. The routine physical exercise program consists primarily of aerobic and flexibility exercises performed at least three times per week for approximately 30 minutes per session.
Receives: Behavioral: Routine Physical Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Walking Speed

    Walking speed is measured in meters per second using a stopwatch on a 10-meter level walkway. The first 2 meters are used for acceleration and the final 2 meters for deceleration. The time required to walk the middle 6 meters at the participant's usual comfortable walking speed is recorded, and walking speed is calculated in meters per second.

    Measured: Baseline and 8 weeks after the intervention period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2026
  2. Study start1 May 2026
  3. Primary completion18 Jul 2026
  4. Study completion18 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07859969
Sponsor's protocol ID
86/EC/KEPK/FKUA/2026
Status last verified
Sep 2026
First submitted
30 Sep 2026
Last updated
13 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made publicly available because the study protocol and informed consent did not include a specific plan for sharing individual-level participant data with external researchers. Participant confidentiality will be maintained, and study results will be reported in aggregate form without identifying individual participants

Publications

  • Kwon I, Kim JS, Shin CH, Park Y, Kim JH. Associations Between Skeletal Muscle Mass, Grip Strength, and Physical and Cognitive Functions in Elderly Women: Effect of Exercise with Resistive Theraband. J Exerc Nutrition Biochem. 2019 Sep 30;23(3):50-55. doi: 10.20463/jenb.2019.0023.

    PubMed 31743974
  • Liao CD, Tsauo JY, Lin LF, Huang SW, Ku JW, Chou LC, Liou TH. Effects of elastic resistance exercise on body composition and physical capacity in older women with sarcopenic obesity: A CONSORT-compliant prospective randomized controlled trial. Medicine (Baltimore). 2017 Jun;96(23):e7115. doi: 10.1097/MD.0000000000007115.

    PubMed 28591061
  • Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.

    PubMed 32033882

Questions about this trial

What is this clinical trial studying?

A study testing Elastic Resistance Training and Routine Physical Exercise in people with Sarcopenia in Elderly, run by Dr. Soetomo General Hospital at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Walking Speed (time frame: Baseline and 8 weeks after the intervention period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07859969, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in